Landry Robert E Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
43
Insider Sells Sum
$19.51M

Insider Activity of Landry Robert E

According to the SEC Form 4 filings, Landry Robert E, being in a position of

  1. director at Cytokinetics, Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 2000 shares for $146,790,
    over all time since 2026-09-11, has bought 0 shares, and sold 2000 shares for $146,790.

Biography of Landry Robert E

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $146,7902100

Comparison of Insiders on Amount of Buys and Sells

2026-09-15SaleCytokinetics, Incorporated
CYTK
director
1,000
0.0008%
$72.13$72,130-9.12%
2026-09-11SaleCytokinetics, Incorporated
CYTK
director
1,000
0.0008%
$74.66$74,660-14.18%
2023-08-23SaleRegeneron Pharmaceuticals, Inc.
REGN
EVP Finance CFO
223
0.0002%
$844.00$188,212+11.99%
2023-03-28SaleRegeneron Pharmaceuticals, Inc.
REGN
EVP Finance CFO
1,007
0.0009%
$823.47$829,233-0.5%
2023-03-27SaleRegeneron Pharmaceuticals, Inc.
REGN
EVP Finance CFO
183
0.0002%
$821.70$150,372+0.3%
2023-02-06SaleRegeneron Pharmaceuticals, Inc.
REGN
EVP Finance CFO
752
0.0007%
$788.88$593,238+2.6%
2023-02-03SaleRegeneron Pharmaceuticals, Inc.
REGN
EVP Finance CFO
739
0.0007%
$764.50$564,966+2.22%
2022-12-02SaleRegeneron Pharmaceuticals, Inc.
REGN
EVP Finance CFO
610
0.0006%
$756.66$461,564+0.64%
2022-11-01SaleRegeneron Pharmaceuticals, Inc.
REGN
EVP Finance CFO
482
0.0004%
$758.06$365,386-0.28%
2022-10-17SaleRegeneron Pharmaceuticals, Inc.
REGN
EVP Finance CFO
358
0.0003%
$739.50$264,741+2.2%
2022-04-07SaleRegeneron Pharmaceuticals, Inc.
REGN
EVP Finance CFO
32
<0.0001%
$743.71$23,799-0.24%
2022-03-31SaleRegeneron Pharmaceuticals, Inc.
REGN
EVP Finance CFO
15
<0.0001%
$701.98$10,530+2.46%
2022-03-28SaleRegeneron Pharmaceuticals, Inc.
REGN
EVP Finance CFO
147
0.0001%
$694.94$102,156+2.96%
2022-03-21SaleRegeneron Pharmaceuticals, Inc.
REGN
EVP Finance CFO
300
0.0003%
$693.00$207,900+2.41%
2022-03-16SaleRegeneron Pharmaceuticals, Inc.
REGN
EVP Finance CFO
83
<0.0001%
$686.00$56,938+4.48%
2021-12-13SaleRegeneron Pharmaceuticals, Inc.
REGN
EVP Finance CFO
116
0.0001%
$662.50$76,850-2.99%
2021-12-10SaleRegeneron Pharmaceuticals, Inc.
REGN
EVP Finance CFO
781
0.0007%
$666.42$520,477-4.5%
2021-11-17SaleRegeneron Pharmaceuticals, Inc.
REGN
EVP Finance CFO
681
0.0006%
$645.08$439,299-1.05%
2021-08-10SaleRegeneron Pharmaceuticals, Inc.
REGN
EVP Finance CFO
537
0.0005%
$611.90$328,593+1.9%
2021-08-09SaleRegeneron Pharmaceuticals, Inc.
REGN
EVP Finance CFO
364
0.0003%
$617.83$224,891+2.02%
Total: 45
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.